Latest filing published 18 Aug 2026 for NEKTAR THERAPEUTICS, €26k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
All filings by Robin Howard W on record concern Nektar Therapeutics. Between 16 June 2026 and 18 August 2026, the trades on record add up to 3 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The newest entry dates from 18 August 2026: a transaction of €26k, in Nektar Therapeutics. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations